Room 2 — Controller Room 2

진행 중: —
--:--

세션 목록 (13개)

16:50~17:501
Latest diabetes technology Latest advances in diabetes technology: CGM, AID, and beyond
예정
1
최훈지 한림의대 내과 16:50-17:05
What's new in AID
2
류영상 조선의대 내과 17:05-17:20
What's new in CGM
3
이다영 고려의대 내과 17:20-17:35
About continuous ketone monitoring (CKM)
08:00~08:152
Breakfast symposium 2 The role of SGLT2i in CKM management
예정
1
오태정 서울의대 내과 08:00-08:15
The role of SGLT2i in CKM management
08:15~08:302
Breakfast symposium 4 Understanding iCGM: what it means and why it matters
예정
1
허지혜 한림의대 내과 08:15-08:30
Understanding iCGM: what it means and why it matters
12:20~12:352
Luncheon symposium 2 GLP-1 therapy for comorbidity management: evidence and clinical insights
예정
1
김혜경 연세의대 내과 12:20-12:35
GLP-1 therapy for comorbidity management: evidence and clinical insights
14:00~15:202
MASH: insulin resistance and inflammation From metabolic regulation to therapeutic innovation in MASH
예정
1
김하일 KAIST 14:00-14:20
Serotonin drives selective hepatic insulin resistance via HTR2A and HTR2B
2
임승순 계명의대 생리학교실 14:20-14:40
Regulatory mechanisms of LRH-1 as a therapeutic target for MASH
3
허진영 서강대 생명과학과 14:40-15:00
Tank-binding kinase 1 protects against MASH progression via mitochondrial quality control
16:30~17:502
Spatial omics & AI Next-generation diabetes research: AI and spatial multi-omics
예정
1
박지환 GIST 16:30-16:50
Integrating single-cell and spatial multi-omics to map the pathological landscape
2
이상열 경희의대 내과 16:50-17:10
Linking clinical phenotypes with spatial omics: AI-driven patient stratification in diabetes
3
박준호 차의학전문대학원 의과학교실 17:10-17:30
Modern LC-MS-based proteomics for spatial omics
08:00~08:153
Breakfast symposium 6 TZD+SGLT-2i combination therapy : benefits for diabetic complications and MASLD
예정
1
홍준화 을지의대 내과 08:00-08:15
TZD+SGLT-2i combination therapy: benefits for diabetic complications and MASLD
08:15~08:303
Breakfast symposium 8 Managing residual atherogenic dyslipidemia in patients with type2 diabetes
예정
1
전자영 아주의대 내과 08:15-08:30
Managing residual atherogenic dyslipidemia in patients with type2 diabetes
09:00~10:203
Meta-inflammation Meta-inflammation in metabolic disease: mechanisms to innovation
예정
1
김효수 서울의대 내과 09:00-09:20
Mechanism of two different actions of PCSK9 through its receptor CAP1/cholesterol elevation in hepatocytes and inflammation in monocytes
2
조재호 전남의대 미생물학및면역학교실 09:20-09:40
Role of glucose uptake regulation in T cell homeostasis
3
김재범 서울대 생명과학부 09:40-10:00
Adipose tissue plasticity upon energy state
12:20~12:353
Luncheon symposium 9 Why it matters: the only SGLT2i/DPP4i fixed-dose combination with original dapagliflozin
예정
1
박찬호 동아의대 내과 12:20-12:35
Why it matters: the only SGLT2i/DPP4i fixed-dose combination with original dapagliflozin
12:35~12:503
Luncheon symposium 13 Optimal clinical approach to combination use of SGLT2i and DPP-4i in the management of T2D
예정
1
류영상 조선의대 내과 12:35-12:50
Optimal clinical approach to combination use of SGLT2i and DPP-4i in the management of T2D
14:00~15:203
Mechanism-driven combination strategy Evidence-based selection of "TZD, SGLT2i, and DPP4i combinations" for personalized and holistic patient management
종료
1
김소헌 인하의대 내과 14:00-14:25
Efficacy & safety: maximizing weight neutrality and hypoglycemia prevention
2
서다혜 인하의대 내과 14:25-14:50
TZD+SGLT2i the ultimate duo: combining insulin sensitization with hemodynamic benefits
3
전재한 경북의대 내과 14:50-15:15
A dual mechanism for metabolic stability: revitalizing beta-cell function and peripheral sensitivity and summary
14:50~16:10Saturday 17 October
The next wave of diabetes technology Unboxing the next wave of diabetes technology and therapeutics
진행중
좌장: Sunghwan Suh (Sungkyunkwan University, Korea) · Jee Hee Yoo (Chung-Ang University, Korea)
1
Jee Hee Yoo Chung-Ang University, Korea 14:50-15:15
Diabetes and MASLD: shared mechanisms and therapeutic targets
2
Rimei Nishimura Jikei University, Japan 15:15-15:40
Top-line phase 2 results of DD01, a dual GLP-1/Glucagon agonist: rapid improvements in liver and metabolic parameters in patients with MASLD/MASH
3
Sun Joon Moon Sungkyunkwan University, Korea 15:40-16:05
Intestinal IL-22 signaling improves glucose homeostasis in obesity